USE OF THERMOSTABLE ENDONUCLEASES FOR GENERATING REPORTER MOLECULES

• US 20100279295A1
• Filed: 03/17/2010
• Published: 11/04/2010
• Est. Priority Date: 03/18/2009
• Status: Abandoned Application

• Current Assignee: Sequenom Incorporated (Laboratory Corporation Of America Holdings), The Scripps Research Institute
• Original Assignee: Sequenom Incorporated (Laboratory Corporation Of America Holdings)
• Inventors: Roy, Margaret Ann, Oeth, Paul Andrew
• Application Number:
  US12/726,246
• Publication Number:
  US 20100279295A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 2525/131 incorporating a restriction site
• CPC Class Codes: C12Q 2525/186 incorporating a non-extendable or blocking moiety
• CPC Class Codes: C12Q 2565/30 Detection characterised by liberation or release of label

Abstract

Provided are compositions and methods for amplifying, capturing and/or detecting target nucleic acids using cleavable oligonucleotides.

Claims

1. A method for amplifying a target nucleic acid, or portion thereof, in a nucleic acid composition, which comprises:

(a) contacting, under hybridization conditions, a nucleic acid composition with an oligonucleotide and a primer polynucleotide, wherein the oligonucleotide comprises;

(i) a nucleotide subsequence complementary to the target nucleic acid, and

(ii) a non-terminal and non-functional portion of a first endonuclease cleavage site; and

(b) extending the oligonucleotide under amplification conditions, thereby generating an extended oligonucleotide, wherein the primer polynucleotide hybridizes to the extended oligonucleotide and is extended under the amplification conditions, thereby yielding a double-stranded amplification product that comprises a functional first endonuclease cleavage site, whereby the target nucleic acid, or portion thereof, is amplified.

2. The method of claim 1, which comprises (c) cleaving the first functional cleavage site with a first endonuclease under cleavage conditions, thereby generating a double-stranded cleavage product.

3. The method of claim 1, wherein the double-stranded cleavage product comprises a detectable feature.

4. The method of claim 3, which comprises detecting the detectable feature.

5. The method of claim 4, wherein the detectable feature is the mass of the double-stranded cleavage product.

6. The method of claim 1, wherein the double-stranded cleavage product comprises a capture agent.

7. The method of claim 1, wherein (a) and (b) are performed in the same reaction environment.

8. The method of claim 1, wherein (a) and (b) are performed contemporaneously.

9. The method of claim 1, which comprises (c) cleaving the first functional cleavage site with a first endonuclease under cleavage conditions, thereby generating a single-stranded cleavage product.

10. The method of claim 1, wherein the single-stranded cleavage product comprises a detectable feature.

11. The method of claim 10, which comprises detecting the detectable feature.

12. The method of claim 11, wherein the detectable feature is the mass of the single-stranded cleavage product.

13. The method of claim 9, wherein the single-stranded cleavage product comprises a capture agent.

14. The method of claim 13, wherein the capture agent is biotin, avidin or streptavidin.

15. The method of claim 1, wherein the first endonuclease cleavage site comprises an abasic site.

16. The method of claim 15, wherein the amplification conditions comprise a trans-lesion synthesizing polymerase.

17. The method of claim 16, wherein the polymerase is a trans-lesion Y-family polymerase.

18. The method of claim 17, wherein the polymerase is a Sulfolobus DNA Polymerase IV.

19. The method of claim 1, wherein two or more target nucleic acids are amplified.

20. A method for detecting the presence or absence of a target nucleic acid in a nucleic acid composition, which comprises:

(a) contacting, under hybridization conditions, a nucleic acid composition with an oligonucleotide and a primer polynucleotide, wherein the oligonucleotide comprises;

(i) a nucleotide subsequence complementary to the target nucleic acid,

(ii) a non-terminal and non-functional portion of a first endonuclease cleavage site, and

(iii) a detectable feature; and

(b) exposing the nucleic acid composition to amplification conditions, wherein (i) the oligonucleotide is extended when the target nucleic acid is present, and (ii) the primer polynucleotide hybridizes to the extended oligonucleotide and is extended under the amplification conditions, thereby yielding a double-stranded amplification product that comprises a functional first endonuclease cleavage site;

(c) contacting the nucleic acid composition with a first endonuclease that cleaves the functional first endonuclease cleavage site, thereby generating a cleavage product comprising the detectable feature; and

(d) detecting the presence or absence of the cleavage product comprising the detectable feature, whereby the presence or absence of the target nucleic acid is detected based on the presence or absence of the cleavage product comprising the detectable feature.

21. The method of claim 20, wherein (a), (b) and (c) are performed in the same reaction environment.

22. The method of claim 20, wherein (a), (b) and (c) are performed contemporaneously.

23. The method of claim 20, wherein the cleaving in (c) generates two or more cleavage products comprising distinguishable detectable features.

24. The method of claim 20, wherein one or more of the detectable features of one or more of the cleavage products are detected.

25. The method of claim 24, wherein the one or more of the detectable features is the mass of the cleavage products.

26. The method of claim 20, wherein one or more of the cleavage products comprise a capture agent.

27. The method of claim 26, wherein the capture agent is biotin, avidin or streptavidin.

28. The method of claim 20, wherein the first endonuclease cleavage site comprises an abasic site.

29. The method of claim 28, wherein the amplification conditions comprise a trans-lesion synthesizing polymerase.

30. The method of claim 29 wherein the polymerase is a trans-lesion Y-family polymerase.

31. The method of claim 30, wherein the polymerase is a Sulfolobus DNA Polymerase IV.

32. The method of claim 20, wherein the presence or absence of two or more target nucleic acids is detected in a multiplex analysis.